Wang Virginia, Zepel Lindsay, Smith Valerie A, Brookhart Maurice A, Bowling Christopher B, Maciejewski Matthew L, Diamantidis Clarissa J
Department of Population Health Sciences, Duke University School of Medicine, Durham, NC.
Department of Medicine, Duke University School of Medicine, Durham, NC.
Med Care. 2025 Feb 1;63(2):98-105. doi: 10.1097/MLR.0000000000002093. Epub 2024 Nov 12.
Community-acquired acute kidney injury (CA-AKI) occurs outside of the hospital and is the most common form of AKI. CA-AKI is not well understood, which hinders efforts to prevent, identify, and manage CA-AKI.
Examine 30-day outcomes following CA-AKI using national administrative and lab data from the Veterans Health Administration (VA).
Retrospective cohort study.
VA primary care patients with recorded outpatient serum creatinine (SCr) with observed CA-AKI (cases) and a standardized mortality ratio propensity-weighted 5% comparator sample without observed CA-AKI in 2013-2017.
CA-AKI was defined as a ≥1.5-fold relative increase in outpatient SCr or inpatient SCr (≤24 h from admission) from a reference outpatient SCr ≤12 months prior. Outcomes were 30-day mortality and hospitalization and were assessed in separate weighted Cox regression models.
Among 220,777 CA-AKI events and 492,539 comparators without observed CA-AKI, CA-AKI was associated with a higher risk of 30-day all-cause mortality [hazard ratio (HR)=4.17, 95% CI: 3.74, 4.63] and hospitalization (HR=1.82, 95% CI: 1.74, 1.90) versus comparator. Risks increased with severity (mortality HR=3.02, 7.67, and 12.22 for AKI stages 1-3, respectively). Outpatient CA-AKI was associated with a high risk of mortality (HR=2.04, 95% CI: 1.83, 2.28) and even higher for inpatient CA-AKI, present [≤24 h from admission (HR=11.32, 95% CI: 10.16, 12.61)].
In a national cohort of Veterans, CA-AKI was associated with a 2-fold increased risk of hospitalization and a 3-11-fold risk of mortality. Improving identification and management is critical to mitigate adverse outcomes of CA-AKI.
社区获得性急性肾损伤(CA-AKI)发生在医院之外,是急性肾损伤最常见的形式。人们对CA-AKI了解不足,这阻碍了预防、识别和管理CA-AKI的工作。
利用退伍军人健康管理局(VA)的国家行政和实验室数据,研究CA-AKI后的30天结局。
回顾性队列研究。
2013 - 2017年有门诊血清肌酐(SCr)记录且观察到CA-AKI的VA初级保健患者(病例组),以及按标准化死亡率倾向加权的5%对照样本,这些对照样本未观察到CA-AKI。
CA-AKI定义为门诊SCr或住院SCr(入院后≤24小时)相对于≤12个月前的参考门诊SCr相对增加≥1.5倍。结局指标为30天死亡率和住院率,并在单独的加权Cox回归模型中进行评估。
在220,777例CA-AKI事件和492,539例未观察到CA-AKI的对照者中,与对照者相比,CA-AKI与30天全因死亡率[风险比(HR)=4.17,95%置信区间(CI):3.74,4.63]和住院率(HR=1.82,95%CI:1.74,1.90)的风险更高相关。风险随严重程度增加(急性肾损伤1 - 3期的死亡率HR分别为3.02、7.67和12.22)。门诊CA-AKI与高死亡率风险(HR=2.04,95%CI:1.83,2.28)相关,住院CA-AKI的死亡率风险更高,即入院后≤24小时出现的情况(HR=11.32,95%CI:10.16,12.61)。
在一个全国性的退伍军人队列中,CA-AKI与住院风险增加2倍和死亡风险增加3 - 11倍相关。改善识别和管理对于减轻CA-AKI的不良结局至关重要。